Outcomes of Triaged Family Care in Advanced Cancer (FOCUS-Triage)

February 10, 2014 updated by: University of Michigan
The purpose of this study is to assess the quality of life of patients with advanced cancer and their family caregivers and to evaluate two doses of a family-based program of care versus control.

Study Overview

Detailed Description

The purpose of this study is to:

  1. determine if family dyads randomly assigned to either a brief or extensive family-based program of care have better proximal and distal outcomes from both a clinical and economic perspective than dyads randomly assigned to usual care
  2. determine if the brief or extensive program of care has a differential effect on patient and caregiver outcomes depending on the patient's baseline risk for distress status (high versus low).

A longitudinal, randomized clinical trial is being used for patients with advanced lung, colorectal, prostate, and breast cancer and their caregivers.

Study Type

Interventional

Enrollment (Actual)

484

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Ann Arbor, Michigan, United States, 48109
        • University of Michigan Comprehensive Cancer Center
      • Ann Arbor, Michigan, United States, 48106
        • St. Joseph Mercy Cancer Center
      • Detroit, Michigan, United States, 48202
        • Wayne State University
      • Detroit, Michigan, United States, 48202
        • Karmanos Cancer Center
      • Southfield, Michigan, United States, 48075
        • Providence Hospital Cancer Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with Stage 3 or 4 breast, prostate, colorectal and lung cancers.
  • Patients must be 21 years old or older, physically and mentally able to participate, speak and understand English, have a minimum life expectancy of six months, live within 75 miles of one of the participating sites and have a family caregiver who is willing to participate in the study.
  • For this study "family caregiver" is defined as the person who provides the patient with physical and/or emotional support during cancer treatment.
  • Family caregivers must be 18 years old or older, physically and mentally able to participate, and speak and understand English.

Exclusion Criteria:

  • Patients will be excluded if they have multiple primary cancer sites.
  • Family caregivers will be excluded if they, themselves, have been diagnosed with cancer during the previous year and/or are in active treatment for cancer.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Brief
Dyads randomized to BRIEF arm received the Brief FOCUS Program (two home visits and one phone call by a trained nurse) in addition to standard clinical care.
Dyads randomized to this arm received the FOCUS Brief Program, two home visits and one phone call by a trained nurse.
Other Names:
  • Family(F),Optimism(O),Coping(C),Uncertainty(U),Symptoms(S)
  • Family-based Intervention
  • Cancer Patient and Family Member Intervention
Experimental: Extensive
Dyads randomized to EXTENSIVE arm received the Extensive FOCUS Program (4 home visits and two phone calls by a trained nurse) in addition to standard clinical care.
Dyads randomized to this arm received the FOCUS Extensive Program, 4 home visits and two phone calls by a trained nurse.
Other Names:
  • Family(F),Optimism(O),Coping(C),Uncertainty(U),Symptoms(S)
  • Family-based Intervention
  • Cancer Patient and Family Member Intervention
No Intervention: Control
Dyads randomized to CONTROL arm continued with standard clinical care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in Quality of Life
Time Frame: Baseline, 3 and 6 months
Baseline, 3 and 6 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Risk for Distress
Time Frame: Baseline
Baseline
Change in Emotional Distress
Time Frame: Baseline, 3 and 6 months
Baseline, 3 and 6 months
Change in Appraisal of Illness/Caregiving
Time Frame: Baseline, 3 and 6 months
Baseline, 3 and 6 months
Change in Uncertainty
Time Frame: Baseline, 3 and 6 months
Baseline, 3 and 6 months
Change in Hopelessness
Time Frame: Baseline, 3 and 6 months
Baseline, 3 and 6 months
Change in Self-efficacy
Time Frame: Baseline, 3 and 6 months
Baseline, 3 and 6 months
Change in Benefits of Illness
Time Frame: Baseline, 3 and 6 months
Baseline, 3 and 6 months
Change in Family Communication
Time Frame: Baseline, 3 and 6 months
Baseline, 3 and 6 months
Change in Support
Time Frame: Baseline, 3 and 6 months
Baseline, 3 and 6 months
Change in Depression
Time Frame: Baseline, 3 and 6 months
Baseline, 3 and 6 months
Change in Coping
Time Frame: Baseline, 3 and 6 months
Baseline, 3 and 6 months
Change in Health Care Resource Utilization
Time Frame: Baseline, 3 and 6 months
Baseline, 3 and 6 months
Change in Caregiver Burden
Time Frame: Baseline, 3 and 6 months
Baseline, 3 and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Laurel L Northouse, PhD, RN, University of Michigan

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2005

Primary Completion (Actual)

May 1, 2010

Study Completion (Actual)

May 1, 2010

Study Registration Dates

First Submitted

July 1, 2008

First Submitted That Met QC Criteria

July 2, 2008

First Posted (Estimate)

July 3, 2008

Study Record Updates

Last Update Posted (Estimate)

February 11, 2014

Last Update Submitted That Met QC Criteria

February 10, 2014

Last Verified

October 1, 2013

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • R01CA107383 (U.S. NIH Grant/Contract)
  • UMCC 2003-094 (Other Identifier: University of Michigan)
  • IRBMED No. 2004-0129 (Other Identifier: University of Michigan)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Advanced Cancer

Clinical Trials on Brief FOCUS Program

3
Subscribe